Product Code: ETC13312611 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Drug Eluting Balloon Market was valued at USD 0.98 Billion in 2024 and is expected to reach USD 1.62 Billion by 2031, growing at a compound annual growth rate of 16.44% during the forecast period (2025-2031).
The Global Drug Eluting Balloon Market is witnessing significant growth driven by the rising prevalence of cardiovascular diseases worldwide. Drug eluting balloons are used in the treatment of coronary artery diseases, peripheral artery diseases, and other conditions by delivering medication directly to the affected area, reducing the risk of restenosis. The market is also propelled by technological advancements in drug coating and balloon design, leading to improved efficacy and patient outcomes. Key players in the market are investing in research and development activities to introduce innovative products and expand their market presence. Geographically, North America and Europe are the dominant regions due to the high incidence of cardiovascular diseases and well-established healthcare infrastructure. However, the Asia-Pacific region is expected to witness rapid growth with increasing awareness and adoption of advanced medical technologies.
The Global Drug Eluting Balloon Market is experiencing rapid growth due to the increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive treatment options. Key trends in the market include the development of next-generation drug-eluting balloons with improved efficacy and safety profiles, expanding applications beyond coronary artery disease to peripheral vascular interventions, and strategic collaborations between medical device companies and research institutions. Opportunities in the market lie in the untapped potential in emerging economies, advancements in drug coating technologies, and the growing acceptance of drug-eluting balloons as a preferred treatment option among healthcare providers and patients. Overall, the market is poised for continued expansion driven by technological advancements and increasing awareness about the benefits of drug-eluting balloons in the treatment of cardiovascular diseases.
The Global Drug Eluting Balloon Market faces several challenges, including regulatory hurdles related to product approval and reimbursement, competition from alternative treatment options such as drug-eluting stents, and the need for continuous innovation to improve efficacy and safety outcomes. Additionally, market fragmentation and pricing pressures contribute to the challenges faced by companies operating in this market. Ensuring the long-term efficacy and safety of drug-eluting balloons, addressing concerns about late restenosis, and expanding market penetration in emerging economies are also key challenges that companies need to navigate in order to maintain a competitive edge and drive growth in this dynamic market.
The Global Drug Eluting Balloon Market is primarily driven by the increasing prevalence of coronary artery disease and peripheral artery disease, leading to a growing demand for minimally invasive treatment options. Drug eluting balloons offer advantages such as reduced rates of restenosis, shorter recovery times, and lower complication rates compared to traditional treatments like stents. Technological advancements in drug coatings and balloon designs are also fueling market growth, enabling more targeted drug delivery and better clinical outcomes. Additionally, the rising adoption of drug eluting balloons by healthcare providers due to their cost-effectiveness and efficacy in improving patient outcomes further contributes to the market expansion. Overall, these factors are expected to drive continued growth in the Global Drug Eluting Balloon Market in the coming years.
Government policies related to the Global Drug Eluting Balloon Market aim to regulate the manufacturing, distribution, and usage of drug-eluting balloons (DEBs) to ensure patient safety and efficacy. Regulatory bodies such as the FDA in the United States and the European Medicines Agency in the EU have established guidelines for the approval and monitoring of DEBs. These policies require manufacturers to conduct rigorous clinical trials to demonstrate the safety and effectiveness of their products before they can be marketed. Additionally, there are ongoing efforts to harmonize regulations across different regions to facilitate market access for DEBs while maintaining high standards of quality and patient care. Compliance with these policies is crucial for companies operating in the DEB market to navigate the complex regulatory landscape and bring innovative products to market successfully.
The Global Drug Eluting Balloon Market is expected to experience steady growth in the coming years due to increasing prevalence of cardiovascular diseases, rising adoption of minimally invasive procedures, and advancements in balloon technologies. The market is projected to be driven by factors such as the effectiveness of drug eluting balloons in reducing restenosis rates after angioplasty, growing geriatric population globally, and expanding healthcare infrastructure in emerging economies. Furthermore, ongoing research and development activities aimed at enhancing the efficacy and safety of drug eluting balloons are likely to fuel market growth. However, challenges such as stringent regulatory requirements and high costs associated with these devices may hinder market expansion to some extent. Overall, the Global Drug Eluting Balloon Market is anticipated to witness promising growth opportunities in the foreseeable future.
In the Global Drug Eluting Balloon Market, Asia Pacific is expected to witness significant growth due to increasing prevalence of cardiovascular diseases and rising adoption of minimally invasive procedures in countries like China and India. North America holds a prominent market share, driven by advanced healthcare infrastructure, high healthcare spending, and increasing incidence of coronary artery disease. Europe is a mature market with a strong presence of key market players and a growing demand for innovative medical technologies. The Middle East and Africa region is projected to experience steady growth, supported by improving healthcare infrastructure and rising awareness about cardiovascular diseases. Latin America is also emerging as a lucrative market, propelled by increasing healthcare expenditure and growing focus on improving healthcare outcomes through advanced medical treatments like drug eluting balloons.
Global Drug Eluting Balloon Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Drug Eluting Balloon Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Drug Eluting Balloon Market Revenues & Volume, 2021 & 2031F |
3.3 Global Drug Eluting Balloon Market - Industry Life Cycle |
3.4 Global Drug Eluting Balloon Market - Porter's Five Forces |
3.5 Global Drug Eluting Balloon Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Drug Eluting Balloon Market Revenues & Volume Share, By Coating Type, 2021 & 2031F |
3.7 Global Drug Eluting Balloon Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Drug Eluting Balloon Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Drug Eluting Balloon Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Drug Eluting Balloon Market Trends |
6 Global Drug Eluting Balloon Market, 2021 - 2031 |
6.1 Global Drug Eluting Balloon Market, Revenues & Volume, By Coating Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Drug Eluting Balloon Market, Revenues & Volume, By Paclitaxel-Eluting Balloons, 2021 - 2031 |
6.1.3 Global Drug Eluting Balloon Market, Revenues & Volume, By Sirolimus-Eluting Balloons, 2021 - 2031 |
6.1.4 Global Drug Eluting Balloon Market, Revenues & Volume, By Everolimus-Eluting Balloons, 2021 - 2031 |
6.1.5 Global Drug Eluting Balloon Market, Revenues & Volume, By Zotarolimus-Eluting Balloons, 2021 - 2031 |
6.2 Global Drug Eluting Balloon Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Drug Eluting Balloon Market, Revenues & Volume, By Coronary Artery Disease (CAD), 2021 - 2031 |
6.2.3 Global Drug Eluting Balloon Market, Revenues & Volume, By Peripheral Artery Disease (PAD), 2021 - 2031 |
6.2.4 Global Drug Eluting Balloon Market, Revenues & Volume, By In-Stent Restenosis (ISR), 2021 - 2031 |
6.2.5 Global Drug Eluting Balloon Market, Revenues & Volume, By Bypass Graft Disease, 2021 - 2031 |
6.3 Global Drug Eluting Balloon Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Drug Eluting Balloon Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Drug Eluting Balloon Market, Revenues & Volume, By Cardiology Clinics, 2021 - 2031 |
6.3.4 Global Drug Eluting Balloon Market, Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031 |
6.3.5 Global Drug Eluting Balloon Market, Revenues & Volume, By Research Institutions, 2021 - 2031 |
7 North America Drug Eluting Balloon Market, Overview & Analysis |
7.1 North America Drug Eluting Balloon Market Revenues & Volume, 2021 - 2031 |
7.2 North America Drug Eluting Balloon Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Drug Eluting Balloon Market, Revenues & Volume, By Coating Type, 2021 - 2031 |
7.4 North America Drug Eluting Balloon Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Drug Eluting Balloon Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Drug Eluting Balloon Market, Overview & Analysis |
8.1 Latin America (LATAM) Drug Eluting Balloon Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Drug Eluting Balloon Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Drug Eluting Balloon Market, Revenues & Volume, By Coating Type, 2021 - 2031 |
8.4 Latin America (LATAM) Drug Eluting Balloon Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Drug Eluting Balloon Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Drug Eluting Balloon Market, Overview & Analysis |
9.1 Asia Drug Eluting Balloon Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Drug Eluting Balloon Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Drug Eluting Balloon Market, Revenues & Volume, By Coating Type, 2021 - 2031 |
9.4 Asia Drug Eluting Balloon Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Drug Eluting Balloon Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Drug Eluting Balloon Market, Overview & Analysis |
10.1 Africa Drug Eluting Balloon Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Drug Eluting Balloon Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Drug Eluting Balloon Market, Revenues & Volume, By Coating Type, 2021 - 2031 |
10.4 Africa Drug Eluting Balloon Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Drug Eluting Balloon Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Drug Eluting Balloon Market, Overview & Analysis |
11.1 Europe Drug Eluting Balloon Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Drug Eluting Balloon Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Drug Eluting Balloon Market, Revenues & Volume, By Coating Type, 2021 - 2031 |
11.4 Europe Drug Eluting Balloon Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Drug Eluting Balloon Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Drug Eluting Balloon Market, Overview & Analysis |
12.1 Middle East Drug Eluting Balloon Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Drug Eluting Balloon Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Drug Eluting Balloon Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Drug Eluting Balloon Market, Revenues & Volume, By Coating Type, 2021 - 2031 |
12.4 Middle East Drug Eluting Balloon Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Drug Eluting Balloon Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Drug Eluting Balloon Market Key Performance Indicators |
14 Global Drug Eluting Balloon Market - Export/Import By Countries Assessment |
15 Global Drug Eluting Balloon Market - Opportunity Assessment |
15.1 Global Drug Eluting Balloon Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Drug Eluting Balloon Market Opportunity Assessment, By Coating Type, 2021 & 2031F |
15.3 Global Drug Eluting Balloon Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Drug Eluting Balloon Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Drug Eluting Balloon Market - Competitive Landscape |
16.1 Global Drug Eluting Balloon Market Revenue Share, By Companies, 2024 |
16.2 Global Drug Eluting Balloon Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |